PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

UC Davis scientists find link between arthritis pain reliever and cardiovascular events

2010-09-13
(Press-News.org) DAVIS--A research team from the University of California, Davis and Peking University, China, has discovered a novel mechanism as to why the long-term, high-dosage use of the well-known arthritis pain medication, Vioxx, led to heart attacks and strokes. Their groundbreaking research may pave the way for a safer drug for millions of arthritis patients who suffer acute and chronic pain.

Using metabolomic profiling to analyze murine (rodent) plasma, the scientists discovered that Vioxx causes a dramatic increase in a regulatory lipid that could be a major contributor to the heart attacks and strokes associated with high levels of the drug and other selective COX-2 inhibitors, known as "coxibs."

"This is a major breakthrough that can lead to a better medication for people suffering from acute pain," said entomologist-chemist Bruce Hammock, a distinguished professor of entomology with a joint appointment at the UC Davis Cancer Center. The research took place in the laboratories of Hammock, cell biologist Nipavan Chiamvimonvat, UC Davis Division of Cardiovascular Medicine; and physiologist Yi Zhu, Peking University.

The research is to be published the week of Sept. 13 in the Proceedings of the National Academy of Sciences.

"Our metabolomics study discovered that 20-hydroxyeicosatetrasanoic acid, also known as 20-HETE, contributes to the Vioxx-mediated cardiovascular events," said UC Davis bioanalytical chemist Jun-Yan Liu, the senior author of the paper and a five-year member of the Bruce Hammock laboratory.

Millions of arthritis patients took Vioxx before its withdrawal from the global market in 2004. Vioxx, a nonsteroidal anti-inflammatory drug (NSAID) and coxib for acute and chronic pain, particularly for arthritis and osteoarthritis, was on the market for five years. Merck & Co. voluntarily withdrew it in September 2004 due to concerns about the increased risk of heart attacks and strokes.

The chronic administration of high levels of selective COX-2 inhibitors, particularly rofecoxib, and valdecoxib, increases the risk for cardiovascular disease, Liu said.

Cardiology expert Garrett J. Gross, professor in the Department of Pharmacology and Toxicology at the Medical College of Wisconsin, Milwaukee, who is not associated with the research, described the UC Davis-based research as "a highly significant finding."

"The recent discovery of Hammock and co-workers at UC Davis that murine plasma concentrations of 20-HETE may be a significant biomarker which may predict the susceptibility of patients to having an unfavorable cardiovascular event while taking selective COX-2 inhibitors such as rofecoxib is an important and novel finding," Gross said. "This discovery may help to unravel the unexpected occurrence and potential mechanism responsible for sudden cardiac death in a number of patients taking COX-2 inhibitors for inflammatory disorders such as arthritis. This a highly significant finding which may lead to a safer use of these drugs in selective patients with disabling inflammatory disorders and may lead to the development of more selective drugs for use in these types of patients."

Urologist Ralph devere White, professor of urology at the UC Davis School of Medicine and director of the UC Davis Cancer Center, described the research as "extremely exciting."

"Vioxx and other drugs in this class were looked on as extremely promising in moderation," devere White said. "The fact that the Hammock lab discovered why the drug could lead to heart attacks and strokes and is able to quantify the deleterious facts is extremely exciting. I hope that patients can safely use this drug in the future or block the deleterious effects so it will have all of the benefits and none of the adverse side effects."

When asked to comment on the research, Richard Roman, professor and chair of the Department of Pharmacology and Toxicology, University of Mississippi Medical Center, with expertise in 20-HETE and cardiology, said: "Rofecoxib (Vioxx) a COX2 inhibitor that was widely used for pain relief was recently withdrawn from the market because it increased the risk of heart attack and stroke. The mechanism of the adverse effects of has not been determined. The study of Hammock et al is important breakthrough because it indicates that Rofecoxib raises the blood levels of 20-HETE which is a potent constrictor of vessels in the heart and brain and they showed it also increases platelet aggregation and clot formation."

"They further demonstrated," Roman said, "that this adverse effect was due to the ability of the compound to inhibit the enzyme COX2 which appears to play a major role in metabolizing and inactivating 20-HETE in the body. Overall this study suggests that the cardiovascular risk associated with Vioxx is not unique to this drug but is likely shared by all members of this class of drugs. It also indicates that one might be able to predict patients that are at risk for a potential cardiovascular event by monitoring serum 20-HETE levels."

"Obviously, more studies are now needed to measure 20-HETE levels in patients treated with COX2 inhibitors because the current study was done in mice and the relative importance of COX2 enzymes in the metabolism of 20-HETE may differ substantially in man versus the mouse."

Nationally, some 46 million individuals suffer from arthritis. "And almost one million patients are admitted to hospitals every year because of their arthritis," Hammock said. "They do need effective and safer drugs to relieve their pain."

The UC Davis scientists predicted their research will open up new strategies to develop safer coxibs. For example, inhibiting the regulation of the enzymes CYP4A and CYP4F could lower the circulation level of 20-HETE and that may reduce the cardiovascular events of coxibs.

The paper, "Metabolic Profiling of Murine Plasma Reveals an Unexpected Biomarker in Rofecoxib-Mediated Cardiovascular Events," is co-authored by Jun-Yan Liu, Ning Li, Jun Yang, Nan Li, Hong Qiu, Ding Ai, Nipavan Chiamvimonvat, Yi Zhu and Bruce Hammock. All are from UC Davis except Nan Li and Yi Zhu, from Peking, while Ding Ai is associated with both Peking University and UC Davis.

INFORMATION: The work was supported in part by grants from the National Institute of Environmental Health Sciences (NIEHS) Superfund and the National Heart, Lung, and Blood Institute (NHLBI), as well as a Veterans Affairs merit review grant; a major National Basic Research grant from China, an American Heart Association Western Affiliates postdoctoral fellowship award and an Elizabeth Nash Memorial Fellowship from the Cystic Fibrosis Foundation.

Hammock directs the NIEHS Superfund Program on the UC Davis campus, as well as the NIH Training Program in Biotechnology, and the NIEHS Combined Analytical Laboratory.


ELSE PRESS RELEASES FROM THIS DATE:

First-of-its-kind study shows supervised injection facilities can help people quit drugs

2010-09-13
A study led by researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul's Hospital and the University of British Columbia has found that supervised injection facilities such as Vancouver's Insite connect clients with addiction treatment, which in turn resulted in greater likelihood of stopping injection drug use for at least six months. The study, recently published in the peer-reviewed journal Drug and Alcohol Dependence, is the first ever to examine the link between a supervised injection facility and injection cessation. "Extensive research has ...

Biofuel from inedible plant material easier to produce following enzyme discovery

2010-09-13
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered key plant enzymes that normally make the energy stored in wood, straw, and other non-edible parts of plants difficult to extract. The findings, published today in Proceedings of the National Academy of Sciences, can be used to improve the viability of sustainable biofuels that do not adversely affect the food chain. The team based at the University of Cambridge, and now part of the BBSRC Sustainable Bioenergy Centre (BSBEC), has identified and studied the genes for ...

Antibiotic appears safe for stroke patients and good companion for tPA

Antibiotic appears safe for stroke patients and good companion for tPA
2010-09-13
An antibiotic appears to be a safe treatment for stroke and a good companion therapy for tPA, the clot buster that is currently the only FDA-approved drug therapy, researchers report. A safety study in 60 stroke patients in Georgia, Kentucky and Oregon found the drug well tolerated even at three-and-one-half times the dose currently used for conditions such as rheumatoid arthritis, according to a research team led by the Medical College of Georgia and the University of Georgia. "It's cheap, safe, well tolerated, easy to administer and can be given with tPA," said Dr. ...

Measures to prevent the loss of foreign investment in Spain

Measures to prevent the loss of foreign investment in Spain
2010-09-13
The theory holds that one of the best ways to attract foreign capital consists in the adoption of a reduced level of taxes in certain cases, and above all, in the provision of legal certainty. This aim of attracting foreign investment inspired the measures for the the Entidades Tenedoras de Valores Extranjeros (ETVE) or Spanish holding companies, adopted in Spain in the late 1990's and which led to the establishment of these companies in Spain by multinational companies. However, things are changing, according the head of the UC3M Research Group of Taxation and Finance ...

Public handwashing takes a hike

2010-09-13
Mom's advice about cleaning your hands may finally be starting to get through. In the latest observational study sponsored by the American Society for Microbiology and the American Cleaning Institute® (formerly The Soap and Detergent Association), 85% of adults washed their hands in public restrooms, compared with 77% in 2007. The 85% total was actually the highest observed since these studies began in 1996. The results were announced at the Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting sponsored by the American Society ...

Can the kids be all right if they are gay too?

2010-09-13
Albany, NY—September 13, 2010— New research on the children of LGBTQ people (lesbian, gay, bisexual, transgender and queer) has unequivocally revealed that they are not only psychologically healthy, but often appear to exhibit better social and academic adjustment and a significantly lower incidence of social problems than their peers. A new article published in the journal Family Process critically examines this research, and how it impacts LGBTQ families. According to Family Therapist and Social Work professor, Arlene Istar Lev these excellent outcomes might be masking ...

Louisiana Tech forestry professor helps to shape future of global industry research

2010-09-13
RUSTON, La – Dr. Bogdan Strimbu, assistant professor of biometrics and quantitative silviculture at Louisiana Tech University's School of Forestry, recently organized and conducted a technical session at the International Union of Forest Research Organization's (IUFRO) XXIII World Congress in Seoul, South Korea. The Congress, held every five years, brings together industry leaders from the IUFRO's eight divisions to help form the future research direction for the global field of forestry. The group also decides the organization's general course of research and associated ...

USGI medical tissue anchors show durability beyond 1 year

2010-09-13
SAN CLEMENTE, Calif. (September 13, 2010) – USGI Medical, Inc., the Incisionless Surgery company, today announced that updated multi-center results confirm durability of the company's Expandable Tissue Anchors™ up to a year or more in a variety of incisionless gastrointestinal (GI) procedures, including use of a ROSE procedure (Repair of Surgery, Endolumenal) to repair dilated tissue after gastric bypass. These findings, which demonstrate long-term, secure tissue approximation with this scarless "through the mouth" approach in the largest cohort of patients ever reported, ...

Nature's gift for gardening may hold key to biodiversity

2010-09-13
Gardeners are used to cross-breeding flowers to produce pretty petals or sweet scents – now scientists have shown the importance of nature's talent for producing new types of flowers. DNA analysis of wild evergreen rhododendrons in the Himalayas has suggested that hundreds of species of the plant could be derived from hybrids – cross-breeds between different species. Their findings may help explain the rich biodiversity of the natural world, as it shows how random pairings of wild plants millions of years ago has led to the development of hundreds of new species that ...

New insights provide promise for development of tools to protect damaged tissues

2010-09-13
St. Jude Children's Research Hospital investigators have identified a novel structure in cells that serves as a control switch in the body's system for eliminating damaged cells and also offers new therapeutic potential. The findings provide fresh insight into the machinery at work as cells ramp up production of p53 protein following DNA damage. The p53 protein plays a critical role in how cells respond to the stress that damages DNA. The gene that carries instructions for making p53 protein is the most commonly mutated gene in human cancers. Investigators also identified ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] UC Davis scientists find link between arthritis pain reliever and cardiovascular events